Patients with atrial fibrillation (AF) suffer from a high risk of thrombosis. Currently, the
CHA2DS2-VASc score is the most widely used tool for risk stratification in patients with AF …

Background: It is unclear whether warfarin treatment with high time in therapeutic range
(TTR) is as effective and safe as non-vitamin K antagonist oral anticoagulants (NOACs). It is …

Stroke, a major global health concern often rooted in cardiac dynamics, demands precise
risk evaluation for targeted intervention. Current risk models, like the CHA 2 DS 2-VASc …

Background: Chronic kidney disease (CKD) is considered a risk factor for thromboembolic
and bleeding events in patients with atrial fibrillation (AF). Aims: We sought to assess …

Background Knowledge about atrial fibrillation (AF) and oral anticoagulation (OAC) is
insufficient among AF patients. Objective We examined the association between this …

Up to 20% of patients with chronic kidney disease have atrial fibrillation, and 40%-50% of
atrial fibrillation patients suffer from chronic kidney disease. The 2 diseases share several …

Background: Atrial fibrillation (AF) is the most common arrhythmia which places a significant
burden on individuals as well as the healthcare system. AF management requires a …

Objective We investigated the association between new-onset atrial fibrillation (AF) and risk
of stroke and myocardial infarction (MI) in patients with abdominal aortic aneurysmal (AAA) …

Aims This study aimed to (1) define the prevalence of vascular disease (VD; coronary (CAD)
and/or peripheral artery disease (PAD)) and associated risk factors in patients with atrial …

The prothrombotic state in patients with atrial fibrillation (AF) is related to endothelial injury,
the activation of platelets and the coagulation cascade. We evaluated the levels of platelet …